OSE IMMUNOTHERAPEUTICSOSE IMMUNOTHERAPEUTICSOSE IMMUNOTHERAPEUTICS

OSE IMMUNOTHERAPEUTICS

No trades
See on Supercharts

OSE fundamentals

OSE IMMUNOTHERAPEUTICS financial statements, including revenue, expenses, profit, and loss

The total revenue of OSE for the last semiannual is 69.05 M EUR, and it's 7845.45% higher compared to the previous semiannual. The net income of H1 24 is 57.17 M EUR.

‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: EUR
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth